We are Sorry, This Page doesn't Exist
Top Analyst Upgrades and Downgrades: AbbVie, Biogen, Boeing, Etsy, Gilead, GoPro, Micron, Newmont, Peloton, Pfizer, Valero, Zynga and More
Thursday's top analyst upgrades, downgrades and initiations included AbbVie, Biogen, Boeing, Etsy, Gilead Sciences, GoPro, Micron Technology, Newmont, Peloton Interactive, Pfizer, Valero Energy and........»»
Pharmaceutical companies celebrated New Year"s by raising the prices on more than 250 drugs
Reuters Drugmakers including Bristol-Myers Squibb Co, Gilead Sciences Inc, and Biogen Inc hiked US list prices on more than 250 drugs on Wednesday. Some of the drugs that will be more expensive include blood thinner Eliquis, HIV.....»»
The Zacks Analyst Blog Highlights: Amarin, Amgen, Gilead Sciences, Biogen and Kiniksa Pharmaceuticals
Zacks.....»»
Drugmakers" Free Services Trigger Anti-Kickback Probe
Federal prosecutors are probing whether big drugmakers including Sanofi, Gilead Sciences and Biogen potentially violated laws by providing free services to doctors and patients......»»
U.S. Probes Drugmakers Over Free Services
Federal prosecutors are probing whether big drugmakers including Sanofi, Gilead Sciences and Biogen potentially violated laws by providing free services to doctors and patients......»»
Amazon, CME, Gilead, Twitter and More Friday Afternoon Analyst Calls
24/7 Wall St. looks at some big analyst calls that we have seen so far on Friday, including Amazon, CME, Gilead Sciences and Twitter......»»
Gilead to donate 450,000 doses of COVID-19 drug to India
Shares of Gilead Sciences Inc. were up 0.1% in premarket trading on Tuesday, the day after the drug maker said it will donate 450,000 doses of its COVID-19 antiviral Veklury to India, which is undergoing an unprecedented surge.....»»
Gilead Sciences Stock Appears To Be Modestly Undervalued
Related Stocks: GILD,.....»»
Gilead names Dr. Flavius Martin new head of research, replacing Bill Lee who is retiring after 30 years at company
Gilead Sciences Inc. said Friday it has appointed Dr. Flavius Martin as executive vice president of research, with the aim of having him lead the company's research organization from April 12, when Bill Lee retires after three decades at the comp.....»»
Gilead"s virology drug head named CEO of East Coast biotech AlloVir
Dr. Diana Brainard, a 10-year veteran of Gilead Sciences Inc. who currently heads up the company's broad virology drug pipeline, will take over as CEO of a young cell therapy company backed by her soon-to-be former employer. Starting May 17, Brain.....»»
Gilead, Novo Nordisk To Test Triple Combo Therapy In New NASH Study
Gilead Sciences Inc (NASDAQ: GILD) and Novo Nordisk A/S (NYSE: read more.....»»
Gilead"s COVID-19 drug to be studied in pregnant women
Shares of Gilead Sciences Inc. were down 0.6% in trading on Thursday, the day after the federal government said it will study the company's COVID-19 drug, Veklury, in pregnant women. The drug, which is also referred to as remdesivir, .....»»
Gilead, Galapagos drug fails in Phase 3 clinical study
Shares of Gilead Sciences Inc. were down 0.1% in premarket trading on Thursday, the day after the company said an experimental idiopathic pulmonary fibrosis drug it was developing with Galapagos failed a Phase 3 clinical trial. Shares o.....»»
Earnings Results: Gilead stock rallies as it reports $1.9 billion in sales for its COVID-19 drug in Q4
Shares of Gilead Sciences Inc.'s stock gained 2.1% in after-hours trading on Thursday after the drug maker surprised investors with better-than-expected sales of its COVID-19 drug Veklury during the fourth quarter of 2020......»»
Gilead buys more Arcus Biosciences stock, at a price above the record close
Arcus Biosciences Inc. disclosed Monday that Gilead Sciences Inc. boosted its stake in the oncology-focused biopharmaceutical company, through the purchase of $220.35 million worth of stock. Arcus shares were still inactive in pr.....»»
Gritstone Oncology shares soar 44% premarket on news of collaboration with Gilead to develop HIV therapy
Shares of Gritstone Oncology Inc. soared 44% in premarket trade Monday, after the company unveiled an agreement with Gilead Sciences Inc. to us.....»»
Gilead Sciences upgraded to overweight at Morgan Stanley
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»
Why Eli Lilly, Exact Sciences, Biogen Are Trading Higher Today
Exact Sciences (NASDAQ: EXAS) shares are trading higher after the company issued fourth-quarter sales guidance above analyst estimates. read more.....»»
Gilead Sciences Raises FY Guidance Due To Remdesivir Sales
CNBC Exclusive: CNBC Transcript: Gilead Sciences Chairman & CEO Daniel O.....»»